tiprankstipranks
Trending News
More News >
United Therapeutics (UTHR)
NASDAQ:UTHR
US Market

United Therapeutics (UTHR) Financial Statements

Compare
679 Followers

United Therapeutics Financial Overview

United Therapeutics's market cap is currently $20.77B. The company's EPS TTM is $7.16; its P/E ratio is 18.07; United Therapeutics is scheduled to report earnings on October 29, 2025, and the estimated EPS forecast is $7.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 2.88B$ 2.33B$ 1.94B$ 1.69B$ 1.48B
Gross Profit$ 2.57B$ 2.07B$ 1.79B$ 1.56B$ 1.38B
Operating Income$ 1.38B$ 1.18B$ 979.70M$ 555.90M$ 593.60M
EBITDA$ 1.65B$ 1.39B$ 1.04B$ 736.80M$ 646.30M
Net Income$ 1.20B$ 984.80M$ 727.30M$ 475.80M$ 514.80M
Balance Sheet
Cash & Short-Term Investments$ 3.27B$ 2.99B$ 2.84B$ 1.93B$ 1.83B
Total Assets$ 7.36B$ 7.17B$ 6.04B$ 5.17B$ 4.62B
Total Debt$ 300.00M$ 700.00M$ 800.00M$ 800.00M$ 800.00M
Net Debt$ -1.40B$ -507.70M$ -161.20M$ -94.80M$ 61.30M
Total Liabilities$ 920.00M$ 1.18B$ 1.25B$ 1.21B$ 1.22B
Stockholders' Equity$ 6.44B$ 5.98B$ 4.80B$ 3.96B$ 3.40B
Cash Flow
Free Cash Flow$ 1.08B$ 747.60M$ 663.70M$ 477.40M$ 696.40M
Operating Cash Flow$ 1.33B$ 978.00M$ 802.50M$ 598.20M$ 755.70M
Investing Cash Flow$ 417.20M$ -719.60M$ -811.50M$ -486.90M$ -738.50M
Financing Cash Flow$ -1.25B$ -11.90M$ 75.40M$ 44.80M$ -16.90M
Currency in USD

United Therapeutics Earnings and Revenue History

United Therapeutics Debt to Assets

United Therapeutics Cash Flow

United Therapeutics Forecast EPS vs Actual EPS